Terug
Dagbereik
€ 8,88
€ 9,08
52-Weeksbereik
€ 8,72
€ 15,55
Volume
680.136
50D / 200D Gem.
€ 10,51
/
€ 12,02
Vorige Slotkoers
€ 9,03
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 5,6 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 8,8 | 3,8 |
| Rev Growth 5Y % | -1,9 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 22,50
+149.7%
Low: € 20,00
High: € 25,00
Forward K/W
3,2
Forward WPA
€ 2,82
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,1 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,06
€ 3,05 – € 3,07
|
940 M | 1 |
| FY2029 |
€ 2,96
€ 2,95 – € 2,97
|
970 M | 1 |
| FY2028 |
€ 2,98
€ 2,35 – € 3,48
|
1,1 B | 3 |
Belangrijkste Punten
Revenue declined -1,87% annually over 5 years
Earnings grew 21,84% over the past year
Generating 182,40M in free cash flow
P/E of 5,59 — trading at a low valuation
PEG of 0,42 suggests growth is underpriced
Cash machine — converts 191,19% of earnings into free cash flow
Groei
Revenue Growth (5Y)
-1,87%
Revenue (1Y)-3,80%
Earnings (1Y)21,84%
FCF Growth (3Y)110,41%
Kwaliteit
Return on Equity
N/A
ROIC31,68%
Net Margin8,83%
Op. Margin30,48%
Veiligheid
Debt / Equity
N/A
Current Ratio2,41
Interest Coverage3,07
Waardering
P/E Ratio
5,59
P/B RatioN/A
EV/EBITDA5,28
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3,80% | Revenue Growth (3Y) | -1,82% |
| Earnings Growth (1Y) | 21,84% | Earnings Growth (3Y) | 16,41% |
| Revenue Growth (5Y) | -1,87% | Earnings Growth (5Y) | -30,75% |
| Profitability | |||
| Revenue (TTM) | 1,08B | Net Income (TTM) | 95,40M |
| ROE | N/A | ROA | 8,75% |
| Gross Margin | 62,89% | Operating Margin | 30,48% |
| Net Margin | 8,83% | Free Cash Flow (TTM) | 182,40M |
| ROIC | 31,68% | FCF Growth (3Y) | 110,41% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,41 |
| Interest Coverage | 3,07 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 5,59 | P/B Ratio | N/A |
| P/S Ratio | 0,49 | PEG Ratio | 0,42 |
| EV/EBITDA | 5,28 | Dividend Yield | 0,04% |
| Market Cap | 533,57M | Enterprise Value | 1,74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,08B | 1,12B | 1,12B | 1,13B | 1,17B |
| Net Income | 95,40M | 78,30M | 70,40M | 223,60M | 414,80M |
| EPS (Diluted) | 1,62 | 1,34 | 1,22 | 3,89 | 7,31 |
| Gross Profit | 679,50M | 728,90M | 749,90M | 774,90M | 800,00M |
| Operating Income | 329,30M | 174,20M | 229,60M | 378,10M | 492,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,09B | 1,29B | 1,21B | 1,09B | 788,00M |
| Total Liabilities | 1,74B | 2,02B | 2,04B | 1,98B | 194,00M |
| Shareholders' Equity | -650,60M | -738,30M | -821,70M | -891,40M | 594,00M |
| Total Debt | 1,43B | 1,61B | 1,64B | 1,64B | 0,0 |
| Cash & Equivalents | 225,50M | 267,50M | 326,30M | 330,90M | 0,0 |
| Current Assets | 631,40M | 761,00M | 749,10M | 664,70M | 292,00M |
| Current Liabilities | 261,50M | 374,00M | 353,50M | 301,00M | 164,00M |